Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to boost living kidney donations

NCT ID NCT04666545

Knowledge-focused Sponsor: University of Alberta Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests a support program called MuST AKT for people with kidney failure who need a transplant. The program helps patients talk to family and friends about living kidney donation. Researchers want to see if this support leads to more potential donors starting the evaluation process. The study includes 38 English-speaking adults who have no obvious barriers to transplant but haven't yet found a living donor.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Multidisciplinary support program (behavioral intervention)
What this could lead to
If successful, this program could help more kidney patients find living donors, leading to more transplants and better outcomes.
What could go wrong
This is a small pilot study with only 38 participants, so results may not apply to everyone. The program may not increase donor evaluations as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

38 people

The number who actually took part.

Started

May 2021

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * English speaking * No obvious contraindication to kidney transplantation * Completed 'introduction to kidney transplant' module Exclusion Criteria: * Potential Living Kidney Donor identified * Previously received organ transplant * Candidate for multi-organ transplant * Stanford Integrated Psychosocial Assessment for Transplant (SIPAT) Score \> 20 * Rapid Estimate of Adult Literacy in Medicine (REALM-66) score \< 19 (illiterate in English)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for End stage kidney disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

end stage renal failure kidney failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Living donor kidney transplantation

Contacts and locations

Locations

  • University of Alberta Hospital

    Edmonton, Alberta, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.